The neurodevelopmental hypothesis of schizophrenia suggests that this disorder may result from a disruption of normal brain development. While widely cited, neuropathological evidence for this is far from conclusive. Alterations in the density and position of white matter neurons have been previously described in the frontal and temporal lobes and have led to suggestions that abnormal neuronal migration may play a role in the aetiology of schizophrenia. However, these findings have not been replicated. Furthermore, developmental abnormalities may not be specific to schizophrenia. The aim of this study was to examine the density and spatial pattern distribution of white matter neurons in psychiatric and control subjects using sophisticated computerised image analysis techniques. White matter neurons immunoreactive for microtubule associated protein-2 were quantified in the frontal lobe in schizophrenia, bipolar disorder, major depressive disorder and matched controls (each group n = 15). Analysis showed that the density and spatial distribution of white matter neurons did not differ significantly between the control and psychiatric groups. This study cannot replicate the earlier findings of white matter abnormalities in schizophrenia and finds no evidence for abnormal brain development in any of the disorders studied.
Introduction
Schizophrenia is a brain disorder believed to result from a developmental, as opposed to a degenerative, process. Although taken individually much of the evidence in support of this theory does not represent conclusive proof, an intriguing picture is emerging from a variety of approaches, including epidemiological and brain imaging studies. 1 Taken together, these studies have led to the suggestion that schizophrenia may result from a disruption of normal brain development during pregnancy or the early postnatal period. This neurodevelopmental hypothesis suggests that a brain abnormality is present early in life but does not fully manifest itself until late adolescence or early adulthood. 2 While an absence of gliosis 3, 4 is considered to support this theory, other neuropathological evidence is less conclusive.
An early study by Jakob and Beckmann described cytoarchitectural abnormalities of the pre-alpha cell clusters in the entorhinal cortex in schizophrenia. This study was one of the most crucial pathological investigations of schizophrenia as it was the first modern neuropathological study to report changes that could only be interpreted in terms of abnormal brain development. Some further investigations of this region support this finding. Falkai and colleagues also described abnormalities in the position and size of pre-alpha cell clusters in the entorhinal cortex in schizophrenia, 6 while Arnold et al have twice reported alterations in cytoarchitecture in this region, the latter study using spatial pattern analysis. 7, 8 However, other groups have failed to find cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. [9] [10] [11] Further evidence for abnormal brain development has been provided by Akbarian and colleagues, who described an altered distribution of interstitial cells in frontal and temporal subcortical white matter in schizophrenia. [12] [13] [14] These studies reported a reduction in the density of neurons in the superficial white matter, but an increased density in deeper white matter, and were interpreted as an indication of aberrant neuronal migration or an abnormality of programmed cell death in schizophrenia. However, a further study essentially failed to replicate these results, finding an increased density of neurons in the superficial white matter in schizophrenia. 15 Following these inconsistent reports of cytoarchitec-tural abnormalities in schizophrenia, it is now imperative that further neuropathological evidence is obtained to support, or refute, the presence of anomalies of early cortical development. Interstitial neurons are amongst the earliest formed neurons of the cortex and are derived from the embryonic subplate, a transient structure critical in cortical development. The subplate consists of early maturing neurons that play a vital role in the orderly development of the overlying cortex and the guidance of thalamocortical afferents. 16, 17 In the late prenatal and early postnatal period the majority of subplate neurons die, with the remaining cells comprising the interstitial neurons of the adult white matter. 18, 19 In the present study we examined the density and spatial distribution of MAP-2 immunoreactive interstitial neurons in the prefrontal white matter in schizophrenia, bipolar disorder (BPD), major depressive disorder (MDD) and control subjects using computerised image analysis.
Methods and materials
Human subjects Human brain specimens were obtained from the Stanley Foundation Brain Consortium. 20 Samples consisted of 60 subjects (15 normal Immunohistochemistry A series of 10-m thick paraffin sections, which contained the dorsolateral prefrontal cortex (Brodmann's areas 9 and 46), were obtained, of which three sections per case were sampled for analysis. Processing for MAP-2 immunohistochemistry was performed in three runs, with one section from each case processed concurrently to minimise variability. Tissue sections were dewaxed then microwaved for 30 min in 0.05 M tris buffer, pH 9.0 to aid antigen retrieval. Sections were incubated with 3% normal serum, then for 36 h at 4°C with a mouse monoclonal antibody against SMI-52 (Sternberger Monoclonals Inc, Baltimore, MD, USA) at a dilution of 1:1000. It has been reported that this antibody recognises human MAP-2. 21 Following this the sections were processed by the avidin-biotin method 22 using a Vectastain ABC kit (Vector Laboratories, Burlingame, CA, USA). Peroxidase was visualised using diaminobenzidine (DAB) and sections counterstained with cresyl violet. Negative control sections, in which the primary antibody was omitted from the staining protocol, were run alongside the test series.
Microscopic image analysis
Images of the frontal lobe were captured using a Leica light microscope with motorised stage and image analysis software (Image-Pro Plus 4.0, Media Cybernet-ics, Silver Spring, MD, USA). This system enabled us to tie together a series of contiguous fields, viewed individually at high magnification (×20 objective), to form a single composite image of the subcortical white matter ( Figure 1a ). For each section the middle frontal sulcus was identified, according to the criteria of Rajkowska and Goldmann-Rakic. 23 The grey-white matter border was easily identified by a sudden reduction in MAP-2 immunoreactivity and marked change in neuronal density. In each section two boxes, each 2.5 mm square, were randomly placed immediately below the grey-white matter border, close to the depths of this sulcus. In all cases the furthest boundary of these boxes was greater than 2.5 mm from the nearest grey-white matter border. Each box was subdivided into five compartments, each 500 m in depth, with compartment 1 adjacent to the grey matter and compartment 5 in the deep white matter. All immunopositive neurons in each white matter compartment were identified and their X-Y co-ordinates recorded. Neurons were defined as immunopositive if intense staining was apparent in the profile of a neuron-shaped cell. For each case the mean neuronal density in each white matter compartment was calculated by summing the total number of immunopositive cells identified within the six boxes and then dividing this value by the area analysed. All counts were performed by one investigator (CLB) who was blind to diagnosis. The reliability of the neuronal density measurements was assessed by quantifying density on two separate occasions in one section from each of ten randomly chosen cases. An intra-rater correlation coefficient of 0.97 was obtained.
To determine if somal size of immunopositive neurons differed between patient and control groups, the size of all clearly labelled cells contained in a box 1.0 mm in length and 0.5 mm in depth, placed randomly in compartment 1 in each section, was quantified. The area of each cell profile was measured by drawing around the perimeter of the cell. Size was recorded for an average of 60 neurons per case.
One section from each case was further examined to determine if any white matter neurons were present which were not immunoreactive for MAP-2. White matter neurons were distinguished from glial cells by the presence of a cresyl violet-stained cytoplasm and nucleolus and by their generally larger size and nonspherical outline.
Statistical analysis
The relative density of neurons in each white matter compartment for each of the three patient groups was compared with that of the control group. The distribution of white matter neuronal density measures was normalized using log transformation, following which between group comparisons were made by univariate analysis of variance (ANOVA), using diagnoses as contrasts. Somal size was similarly compared between each of the patient groups and the control group. The demographic and histological variables listed in Table  1 were considered to be potential confounders of group differences if they differed between the psychiatric groups and the control group according to t-tests or chisquared tests and could also be shown to empirically predict neuronal densities at the 10% significance level according to ANOVA or Spearman's Rank correlation. Where necessary group comparisons were adjusted for confounders identified in this way. All analyses were carried out in SPSS10.
The spatial arrangement of white matter neurons was analysed using a refined nearest neighbour analysis. Differences in spatial pattern arrangement between each of the patient groups and the control group were assessed by comparing K-functions. The degree of spatial clustering or regularity can be quantified using Ripley's K-function. 24 The K-function basically assesses how many cells occur within a specific distance of an arbitrary cell as this distance changes. The K-function at distance t, K(t), is defined as 25 Importantly the K-function is unchanged by neuronal density so cases can be grouped together.
Firstly each individual case was assessed to determine whether or not the spatial arrangement of neurons deviated from CSR. A Monte-Carlo randomisation procedure was used to determine probability values. A method for comparing cell pattern arrangements between groups has previously been described by Diggle and colleagues. 26 Their procedure uses bootstrapping of K-function residuals to derive a statistical test for an overall effect of group membership. This method was extended to include individual replicate sections and was employed to allow pair-wise comparisons of the degree of spatial clustering between each of the psychiatric groups and the control group. 27 We used 999 bootstrap simulations when comparing groups. Empirical K-functions were calculated in 5-m steps up to a maximum search radius of t 0 = 500 m, which amounted to approximately a quarter of the side of the boundary boxes. The analyses were carried out in S-PLUS 2000 using the SpatialStats module, Splancs and in-house written functions.
Results
Immunocytochemistry for MAP-2 revealed large numbers of intensely stained white matter neurons in all cases. While these neurons possessed a variety of morphologies, we noted that the majority of immunoreactive neurons in the subcortical white matter were bipolar or multipolar cells (Figure 1b) . In all of the groups studied the density of MAP-2 positive cells was highest immediately below cortical layer VI, and decreased with increasing distance from the grey-white matter border (Figure 1c) . We did not identify any cells that were clearly neuronal and not immunoreactive for MAP-2.
At the 10% level no significant correlations were observed between neuronal density and age, PMI, tissue pH, or time in fixative. There was also no effect of gender or side of brain and so these variables were not included in the analysis as covariates. Univariate ANOVA indicated no significant differences in the density of MAP-2 immunoreactive neurons between any of the patient groups and the control group either across all white matter compartments (Figure 2 ) or within any individual compartment (Table 2 ). In the schizophrenic group no significant correlations were noted between neuronal density and lifetime antipsychotic dose. The median cross-sectional area of stained neurons correlated significantly with time in fixative (r = −0.321, P = 0.012) but not with age, postmortem interval, tissue pH or, in the schizophrenic group, lifetime antipsychotic dose. As time in fixative differed significantly between the control and psychiatric groups (F = 3.550, P = 0.020), this variable was used as a covariate in the analysis. ANCOVA indicated that the median somal area of MAP-2 immunoreactive neurons did not Molecular Psychiatry differ significantly between any of the patient groups and the control group (Table 2) .
Spatial pattern analysis of neuronal arrangement confirmed significant departures from complete spatial randomness for all individuals, with empirical K-functions indicating clustering in each case (P Ͻ 0.01). While each group individually showed significant departures from CSR, comparison of K-functions between each of the psychiatric groups and the control group did not show any significant differences in the degree of clustering of white matter neurons (controls vs schizophrenia: P = 0.208, BPD: P = 0.861, MDD: P = 0.212, Figure 3 ).
Discussion
The appearance and distribution of MAP-2 immunoreactive neurons in the white matter of the middle frontal sulcus was similar to that described previously. 14, 15 In all groups stained neurons were observed predominantly in the superficial white matter, with density decreasing with increasing distance from the greywhite matter border. We found no significant differences in the density of MAP-2 immunoreactive white matter neurons between controls and patients with schizophrenia, bipolar disorder and major depressive disorder, nor could we find evidence for abnormal spatial pattern distribution in any of the patient groups studied.
Our findings do not support the notion that there is an altered distribution of white matter neurons in schizophrenia. We cannot replicate the results of a previous study, in the same brain region, that found a significant increase in the density of MAP-2 positive neurons in the superficial white matter when comparing five schizophrenics and five control cases. 15 Nor are we able to replicate the maldistribution of white matter neurons observed in a second study by Akbarian et al. 14 It should be noted that in the latter investigation a significant increase in the density of MAP-2 immunoreactive neurons was found only in the deepest white matter compartment analysed (greater then 6000 m deep to the overlying cortex), which neither we nor Anderson et al 15 were able to examine. Furthermore, it has also been suggested that abnormalities in the distribution of white matter neurons may be seen only in a subset of cases. In a small study of the inferior parietal cortex, which quantified differences between three schizophrenics with deficit syndrome, six non-deficit patients and nine controls, it was found that neurons were increased in the superficial white matter in the deficit group but not in the non-deficit patients, when compared with controls. 28 We were not able to examine effects of such subtypes in our cases.
Molecular Psychiatry
As previous reports of cytoarchitectural abnormalities in schizophrenia involve particularly subtle changes, we believe that there is a need for a more penetrative method of analysis. It is our opinion that the recently developed techniques for spatial cellular pattern analysis may be sensitive enough to allow subtle changes in neuronal position and clustering to be detected. Abnormalities in pyramidal cell pattern distribution have previously been observed in the frontal cortex in schizophrenia, 26 while our group has, by this method, shown evidence for selective neuronal loss correlating with dementia in HIV infection. 29 Using this method of analysis we observed significant departures from CSR for all individuals, which we suggest may result from the gradient in the density of neurons from superficial to deep white matter, which was present in each case. However, we found no statistically significant differences in the degree of clustering of white matter neurons in any of the disease groups studied.
Developmental abnormalities may not be specific to schizophrenia, in fact there are suggestions that bipolar disorder may also have a developmental aetiology. While studies of bipolar disorder are limited in number, in part due to diagnostic considerations, some epidemiologic risk factors, along with gross and microscopic pathologies, have been identified that are shared with schizophrenia. 30 Indeed postmortem neuropathological studies have revealed similarities between schizophrenia and bipolar disorder, including reductions in levels of reelin, a secreted glycoprotein which plays a vital role in normal cortical lamination, 31 and reductions in glial density in both disorders. 32, 33 This was the first study to quantitatively assess white matter neurons in bipolar disorder and major depressive disorder. As in the schizophrenic group, no differences in the density or spatial pattern distribution of white matter neurons were observed between the bipolar disorder and major depression groups and the control group.
Neuronal size could be a confounding factor in this two-dimensional study. However, we observed that the average somal size in compartment 1 (which contained the majority of neurons), although slightly smaller in the patient groups, was not significantly different between the four cohorts studied. This is consistent with two previous 2-D studies of white matter neurons, 12, 15 which also found no significant differences in cell size between schizophrenics and controls. Other potential confounders include post-mortem interval and time in fixative. While both of these variables differed between the control and schizophrenic groups, neither were found to be empirical predictors of neuronal density in the white matter.
This investigation has found no evidence for alterations in the density or spatial pattern distribution of white matter neurons in schizophrenia, bipolar disorder or major depressive disorder. We cannot replicate the earlier findings of white matter abnormalities in schizophrenia, which have previously been cited as providing support for the developmental hypothesis of schizophrenia, and can provide no evidence for abnormalities of brain development in any of the disorders studied.
